Q3 2021 Hansa Biopharma AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Hansa Biopharma Q3 earnings calls. (Operator Instructions) Today, I am pleased to present CEO, Søren Tulstrup.
Speaker, please begin.
¸ - ()-&
Thank you. Good afternoon. Good morning. Welcome to the Hansa Biopharma conference call on the results from the first 9 months of 2021. I'm Søren Tulstrup, CEO of Hansa Biopharma. With me today, I have our CFO, Donato Spota as well as our Head of Investor Relations, Klaus Sindahl.
Today, we'll review the overall progress and highlights of our business in the most recent quarter and provide a preview of our near-term milestones. Our presentation should take around 15 to 20 minutes. And after that, we'll take your questions.
Please turn to Slide 2. Please allow me to draw your attention to the fact that I'll be making forward-looking statements during this presentation, and you should therefore apply appropriate caution.
Please
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |